A Recombinant Bispecific CD20×CD95 Antibody With Superior Activity Against Normal and Malignant B-cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Recombinant Bispecific CD20×CD95 Antibody With Superior Activity Against Normal and Malignant B-cells

Published:2016-02 Issue:2 Volume:24 Page:298-305
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Nalivaiko Kristina,Hofmann Martin,Kober Karina,Teichweyde Nadine,Krammer Peter H,Rammensee Hans-Georg,Grosse-Hovest Ludger,Jung Gundram

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference31 articles.

1. Translational medicine in action: anti-CD20 therapy in lymphoma;Lim;J Immunol,2014

2. Anti-B cell antibody therapies for inflammatory rheumatic diseases;Faurschou;Annu Rev Med,2014

3. The future of B cell-targeted therapies in Sjögren's syndrome;Cornec;Immunotherapy,2013

4. Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review;Castillo-Trivino;PLoS One,2013

5. Emerging injectable therapies for multiple sclerosis;Oh;Lancet Neurol,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in cancer immunotherapies targeting CD20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells;Frontiers in Immunology;2024-04-04

2. IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases;Cancers;2022-08-16

3. Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases;Cell Death & Disease;2022-03-17

4. Glofitamab CD20-TCB bispecific antibody;Leukemia & Lymphoma;2021-07-15

5. A review of bispecific antibodies and antibody constructs in oncology and clinical challenges;Pharmacology & Therapeutics;2019-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3